Join
Live feed
·
INSIDERFilingvia Quantisnow
Eagle Pharmaceuticals Inc. logo

SEC Form 4: Tarriff Scott covered exercise/tax liability with 3,827 shares, decreasing direct ownership by 0.24% to 1,575,879 units to satisfy tax liability

ByQuantisnow·Wall Street's wire, on your screen.
EGRX· Eagle Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EGRX (Eagle Pharmaceuticals Inc.) and more on Quantisnow.